(GSK) GlaxoSmithKline - Performance -7.1% in 12m
Compare GSK with Indices, Sectors and Commodities and Bonds. Who performs better in which timeframe?
Performance Rating
9.22%
#60 in Group
Rel. Strength
37.51%
#4798 in Universe
Total Return 12m
-7.09%
#83 in Group
Total Return 5y
25.13%
#61 in Group
P/E 24.2
58th Percentile in Group
P/E Forward 8.81
18th Percentile in Group
PEG 0.38
25th Percentile in Group
FCF Yield 4.53%
61th Percentile in Group
12m Total Return: GSK (-7.1%) vs XLV (-0.6%)
5y Drawdown (Underwater) Chart
Top Performers in Pharmaceuticals
Overall best picks of Peer Group Selected by proven GARP Predictive Metrics, sorted by Growth Rating
| Symbol | 1m | 12m | 5y | P/E | P/E Forward | PEG | EPS Stability |
EPS CAGR |
|---|---|---|---|---|---|---|---|---|
| LLY NYSE Eli Lilly |
-13.4% | 6.56% | 513% | 70 | 36 | 1.21 | 40.3% | 34.5% |
| IPN PA Ipsen |
-4.44% | 2.34% | 143% | 25.2 | 10.6 | 0.76 | -2.70% | -6.33% |
| SFZN SW Siegfried Holding |
-6.55% | 3.64% | 125% | 24.8 | 22.8 | 1.45 | 66.7% | 72.5% |
| NVS NYSE Novartis |
2.65% | 18.5% | 69.6% | 19 | 13.6 | 1.3 | 36.2% | 11.6% |
| SAN PA Sanofi |
-5.26% | 20% | 51.7% | 23.2 | 12.2 | 1.12 | -22.1% | -24.8% |
| SOBI ST Swedish Orphan Biovitrum |
-11% | 8.35% | 67% | 26 | 19.9 | 1.54 | 11.8% | 14.7% |
| SUPN NASDAQ Supernus Pharmaceuticals |
-0.19% | -5.49% | 82.9% | 24.5 | 20.2 | 1.47 | -20.8% | -17% |
| AZN NASDAQ AstraZeneca |
-4.6% | 10.1% | 85.2% | 34.1 | 17 | 1.07 | 43.2% | -20.1% |
Performance Comparison: GSK vs XLV vs S&P 500
XLV (Health Care Sector SPDR ETF) is the Sector Benchmark for GSK
| Total Return (including Dividends) | GSK | XLV | S&P 500 |
|---|---|---|---|
| 1 Month | -0.21% | -3.80% | -3.62% |
| 3 Months | 12.77% | 4.57% | -3.76% |
| 12 Months | -7.09% | -0.56% | 8.80% |
| 5 Years | 25.13% | 78.67% | 143.09% |
| Trend Score (consistency of price movement) | GSK | XLV | S&P 500 |
| 1 Month | -46.1% | -54.2% | -17.5% |
| 3 Months | 91.4% | 53.1% | -55.3% |
| 12 Months | -55.7% | 20.4% | 84.8% |
| 5 Years | 38.3% | 90.4% | 84.4% |
| Relative Strength (compared with Indexes) | Rank in Peer Group | vs. XLV | vs. S&P 500 |
| 1 Month | #55 | 3.73% | 3.53% |
| 3 Month | #30 | 7.84% | 17.2% |
| 12 Month | #82 | -6.57% | -14.6% |
| 5 Years | #64 | -30.0% | -48.5% |
FAQs
Does GSK GlaxoSmithKline outperforms the market?
No,
over the last 12 months GSK made -7.09%, while its related Sector, the Health Care Sector SPDR (XLV) made -0.56%.
Over the last 3 months GSK made 12.77%, while XLV made 4.57%.
Over the last 3 months GSK made 12.77%, while XLV made 4.57%.
Performance Comparison GSK vs Indeces and Sectors
GSK vs. Indices GSK is Over or Underperforming
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| US S&P 500 | SPY | 0.68% | 3.41% | -3.19% | -15.9% |
| US NASDAQ 100 | QQQ | 2.37% | 4.55% | -2.43% | -14.0% |
| US Dow Jones Industrial 30 | DIA | -0.38% | 2.50% | -4.22% | -15.0% |
| German DAX 40 | DAX | 0.76% | 2.60% | -21.0% | -29.5% |
| Shanghai Shenzhen CSI 300 | CSI 300 | -0.31% | -0.48% | 5.02% | -16.2% |
| Hongkong Hang Seng | HSI | -2.12% | -2.69% | 1.20% | -25.3% |
| India NIFTY 50 | INDA | 0.06% | -7.01% | 7.71% | -6.95% |
| Brasil Bovespa | EWZ | -0.78% | -8.50% | 3.41% | 4.15% |
GSK vs. Sectors GSK is Over or Underperforming
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Communication Services | XLC | 1.59% | 3.93% | -11.2% | -25.7% |
| Consumer Discretionary | XLY | 1.27% | 5.41% | -4.36% | -17.4% |
| Consumer Staples | XLP | -5.79% | 1.34% | -4.06% | -17.9% |
| Energy | XLE | -2.67% | -8.08% | -10.3% | -9.17% |
| Financial | XLF | -0.49% | 3.29% | -15.1% | -27.7% |
| Health Care | XLV | -0.51% | 3.59% | 1.74% | -6.53% |
| Industrial | XLI | 0.15% | 1.41% | -1.97% | -14.1% |
| Materials | XLB | -1.59% | 0.10% | 5.43% | -2.02% |
| Real Estate | XLRE | -3.20% | 2.94% | 0.14% | -18.7% |
| Technology | XLK | 2.90% | 4.51% | 1.34% | -7.37% |
| Utilities | XLU | -4.61% | -0.56% | -2.49% | -31.9% |
| Aerospace & Defense | XAR | 3.02% | 0.10% | -6.29% | -24.4% |
| Biotech | XBI | 8.40% | 8.48% | 16.3% | 9.50% |
| Homebuilder | XHB | 0.58% | 1.28% | 17.5% | 4.01% |
| Retail | XRT | -0.90% | 2.44% | 3.58% | 2.38% |